Durable Progression-Free Survival With the Use of BRAF and MEK Inhibitors in Four Cases With V600E-Mutated Gliomas von Michael J. Fusco PharmD, Yolanda Piña MD, Robert J. Macaulay MD, Solmaz Sahebjam MD, Peter A. Forsyth MD, Edwin Peguero MD, Christine M. Walko PharmD

Volltext

Relationship Between Intravenous Busulfan Pharmacokinetics and Patient Characteristics in Allogeneic Stem Cell Transplant von Keisler, Meredith D., PharmD, Simmons, Ashley E., PharmD, Ivanova, Anastasia, PhD, Walko, Christine M., PharmD, BCOP

Volltext

Differential Impact of Dose Escalated Busulfan on Allogeneic Transplant for High, Intermediate and Low Risk Disease von Shea, Thomas C., MD, Walko, Christine M., PharmD, BCOP, Chung, Yunro, Ivanova, Anastasia, PhD, Rao, Kamakshi V., PharmD, Coghill, James, MD, Sarantopoulos, Stefanie, MD, PhD, Wood, William A., MD, MPH, Armistead, Paul, MD, PhD, Gabriel, Don A., MD, PhD, Serody, Jonathan S., MD

Volltext